Dexcom Q3 2023 Adj. EPS $0.50, Revenue $969.1M Beats $939.2M Estimate
Portfolio Pulse from Benzinga Newsdesk
Dexcom has reported its Q3 2023 adjusted EPS at $0.50, beating estimates. The company's revenue for the quarter was $969.1M, surpassing the estimate of $939.2M.
October 26, 2023 | 8:07 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Dexcom's Q3 2023 earnings beat estimates, with an adjusted EPS of $0.50 and revenue of $969.1M, which is likely to positively impact the company's stock.
Dexcom's Q3 2023 earnings have surpassed estimates, which is generally seen as a positive sign by investors and can lead to an increase in the company's stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100